Literature DB >> 16892441

Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs.

D V Baklanov1, K M Moodie, F E McCarthy, E Mandrusov, J Chiu, G Aswonge, J Cheng, M Chow, M Simons, E D de Muinck.   

Abstract

UNLABELLED: We compared two routes for myocardial delivery of therapeutics, transendocardial (TE) delivery with an intramyocardial injection catheter, and retrograde coronary venous (RCV) delivery with a balloon occlusion catheter in the interventricular vein.
METHODS: TE and RCV injection of 15 microM, neutron-activatable microspheres was compared in healthy pigs (Group I, n = 3), pigs with a 1-week-old myocardial infarction (MI; group II, n = 5), and pigs with a 2-weeks-old MI (group III, n = 4). The MI was induced by a 1-hr balloon occlusion in the LAD. Both methods were compared in the same animal using different microspheres. The RCV catheter allowed for continuous measurement of distal pressure and 2.5 x 10(6) microspheres were injected in 10 ml at 300 mmHg above balloon occlusion pressure. The TE injections were targeted to the infarct zone and 2.5 x 10(6) microspheres were distributed over 10 injections of 200 microl.
RESULTS: The retention of microspheres decreased with increase in MI age, but was comparable between devices within the groups. RCV delivery resulted in (14.3 +/- 0.9)% microsphere retention in Group I, (10.3 +/- 0.2)% in Group II, and (6.4 +/- 0.1)% in group III (P < 0.05 versus group I). Microsphere retention after TE was (15.1 +/- 0.7)% in group I, (18.9 +/- 0.6)% in group II, (4.1 +/- 0.1)% in Group III (P < 0.05 versus groups I and II). The RCV catheter delivered primarily to midventricular, antero-septal segments, whereas TE targeted apical areas predominantly.
CONCLUSIONS: Delivery efficacy was comparable between devices in each group however RCV targeted midventricular areas whereas TE targeted apical areas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16892441     DOI: 10.1002/ccd.20841

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

1.  Validation of QwikStar Catheter for left ventricular electromechanical mapping with NOGA XP system.

Authors:  Marlos R Fernandes; Guilherme V Silva; Yi Zheng; Edie M Oliveira; Cristiano O Cardoso; John Canales; Ricardo Sanz-Ruiz; Pilar Jimenez-Quevedo; Fred Baimbridge; Emerson C Perin
Journal:  Tex Heart Inst J       Date:  2008

Review 2.  Human coronary venous anatomy: implications for interventions.

Authors:  Julianne H Spencer; Sara E Anderson; Paul A Iaizzo
Journal:  J Cardiovasc Transl Res       Date:  2013-01-11       Impact factor: 4.132

3.  Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction.

Authors:  Jon C George; Jonathan Goldberg; Matthew Joseph; Nasreen Abdulhameed; Joshua Crist; Hiranmoy Das; Vincent J Pompili
Journal:  J Interv Cardiol       Date:  2008-10       Impact factor: 2.279

Review 4.  Gene and cell therapy for heart failure.

Authors:  Ebo D de Muinck
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 5.  Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium.

Authors:  Tycho I G van der Spoel; Joe Chun-Tsu Lee; Krijn Vrijsen; Joost P G Sluijter; Maarten Jan M Cramer; Pieter A Doevendans; Eric van Belle; Steven A J Chamuleau
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-25       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.